Last 12 months
Inside the activity.
0 purchase rows · 10 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 23, 2025 Filed Jul 25, 2025 21:00 UTC |
Sherbet EricSee Remarks
|
Exercise / conversionCommon Stock | 11,870 | $97.20 | $1,153,764.00 |
DisclosureSEC source: 0001478242-25-000109 · wk-form4_1753477250.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,978 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2025 Filed May 9, 2025 20:50 UTC |
DANHAKL JOHN GDirector
|
GrantDeferred Shares · Derivative | 196 | $153.30 | $30,046.80 |
DisclosureSEC source: 0001478242-25-000092 · wk-form4_1746823810.xml · derivative · entry 1 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,465 Underlying: Common Stock · 196 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| May 07, 2025 Filed May 9, 2025 20:51 UTC |
Wims Morris LeslieDirector
|
GrantDeferred Shares · Derivative | 179 | $153.30 | $27,440.70 |
DisclosureSEC source: 0001478242-25-000095 · wk-form4_1746823897.xml · derivative · entry 1 Wims Morris Leslie · CIK 0001908079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,452 Underlying: Common Stock · 179 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| May 07, 2025 Filed May 9, 2025 20:50 UTC |
Fasano JimDirector
|
GrantDeferred Shares · Derivative | 244 | $153.30 | $37,405.20 |
DisclosureSEC source: 0001478242-25-000093 · wk-form4_1746823842.xml · derivative · entry 1 Fasano Jim · CIK 0001633043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,683 Underlying: Common Stock · 244 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| May 07, 2025 Filed May 9, 2025 20:51 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 229 | $153.30 | $35,105.70 |
DisclosureSEC source: 0001478242-25-000094 · wk-form4_1746823870.xml · derivative · entry 1 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,347 Underlying: Common Stock · 229 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| April 24, 2025 Filed Apr 25, 2025 22:20 UTC |
DANHAKL JOHN GDirector
|
GrantCommon Stock | 1,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-25-000075 · wk-form4_1745619562.xml · nonDerivative · entry 1 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 29,041 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. F2 · ownership.nature: Shares held in the Danhakl Revocable Family Trust. Read SEC document |
| April 24, 2025 Filed Apr 25, 2025 22:20 UTC |
Burt CarolDirector
|
GrantDeferred Shares · Derivative | 1,592 | $150.68 | $239,882.56 |
DisclosureSEC source: 0001478242-25-000076 · wk-form4_1745619632.xml · derivative · entry 1 Burt Carol · CIK 0001493926 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,639 Underlying: Common Stock · 1,592 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| April 24, 2025 Filed Apr 25, 2025 22:19 UTC |
Fasano JimDirector
|
GrantDeferred Shares · Derivative | 1,592 | $150.68 | $239,882.56 |
DisclosureSEC source: 0001478242-25-000074 · wk-form4_1745619534.xml · derivative · entry 1 Fasano Jim · CIK 0001633043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,439 Underlying: Common Stock · 1,592 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| April 24, 2025 Filed Apr 25, 2025 22:18 UTC |
GOGGINS COLLEEN ADirector
|
GrantCommon Stock | 1,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-25-000073 · wk-form4_1745619500.xml · nonDerivative · entry 1 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,882 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
| April 24, 2025 Filed Apr 25, 2025 22:17 UTC |
LEONARD JOHN MDirector
|
GrantCommon Stock | 1,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-25-000072 · wk-form4_1745619471.xml · nonDerivative · entry 1 LEONARD JOHN M · CIK 0001563584 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,375 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
| April 24, 2025 Filed Apr 25, 2025 22:17 UTC |
Wims Morris LeslieDirector
|
GrantDeferred Shares · Derivative | 1,592 | $150.68 | $239,882.56 |
DisclosureSEC source: 0001478242-25-000071 · wk-form4_1745619438.xml · derivative · entry 1 Wims Morris Leslie · CIK 0001908079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,273 Underlying: Common Stock · 1,592 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| April 24, 2025 Filed Apr 25, 2025 22:16 UTC |
Stamps Sheila ADirector
|
GrantDeferred Shares · Derivative | 1,592 | $150.68 | $239,882.56 |
DisclosureSEC source: 0001478242-25-000070 · wk-form4_1745619404.xml · derivative · entry 1 Stamps Sheila A · CIK 0001600782 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,639 Underlying: Common Stock · 1,592 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 22:13 UTC |
Cherofsky KeriannSee Remarks
|
Tax withholdingCommon Stock | 16 | $206.97 | $3,311.52 |
DisclosureSEC source: 0001478242-25-000038 · wk-form4_1739398372.xml · nonDerivative · entry 1 Cherofsky Keriann · CIK 0001940591 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,459 Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 22:13 UTC |
Patel BhavikSee Remarks
|
Tax withholdingCommon Stock | 108 | $206.97 | $22,352.76 |
DisclosureSEC source: 0001478242-25-000039 · wk-form4_1739398407.xml · nonDerivative · entry 1 Patel Bhavik · CIK 0002023629 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,124 Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 22:14 UTC |
STAUB W RICHARDSee Remarks
|
Tax withholdingCommon Stock | 141 | $206.97 | $29,182.77 |
DisclosureSEC source: 0001478242-25-000041 · wk-form4_1739398467.xml · nonDerivative · entry 1 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,896 Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 22:14 UTC |
Sherbet EricSee Remarks
|
Tax withholdingCommon Stock | 179 | $206.97 | $37,047.63 |
DisclosureSEC source: 0001478242-25-000040 · wk-form4_1739398438.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,108 Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 22:12 UTC |
Bruehlman Ronald ESee Remarks
|
Tax withholdingCommon Stock | 907 | $206.97 | $187,721.79 |
DisclosureSEC source: 0001478242-25-000037 · wk-form4_1739398341.xml · nonDerivative · entry 1 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,569 Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 22:11 UTC |
BOUSBIB ARIDirector · See Remarks
|
Exercise / conversionStock Appreciation Right · Derivative | 40,000 | $65.16 Strike: $65.16 | $2,606,400.00 |
DisclosureSEC source: 0001478242-25-000036 · wk-form4_1739398309.xml · derivative · entry 5 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2025-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 22:11 UTC |
BOUSBIB ARIDirector · See Remarks
|
Tax withholdingCommon Stock | 3,335 | $206.97 | $690,244.95 |
DisclosureSEC source: 0001478242-25-000036 · wk-form4_1739398309.xml · nonDerivative · entry 3 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 807,163 Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 22:11 UTC |
BOUSBIB ARIDirector · See Remarks
|
Disposition to issuerCommon Stock | 26,585 | $206.97 | $5,502,297.45 |
DisclosureSEC source: 0001478242-25-000036 · wk-form4_1739398309.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 810,498 F1 · shares: Represents the exercise of stock appreciation rights expiring on February 10, 2025. The transaction occurred between the reporting person and the issuer and did not involve a sale or other transaction with the market. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 22:11 UTC |
BOUSBIB ARIDirector · See Remarks
|
Exercise / conversionCommon Stock | 40,000 | $65.16 | $2,606,400.00 |
DisclosureSEC source: 0001478242-25-000036 · wk-form4_1739398309.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 837,083 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the exercise of stock appreciation rights expiring on February 10, 2025. The transaction occurred between the reporting person and the issuer and did not involve a sale or other transaction with the market. Read SEC document |
| February 05, 2025 Filed Feb 8, 2025 00:03 UTC |
DANHAKL JOHN GDirector
|
GrantDeferred Shares · Derivative | 146 | $205.44 | $29,994.24 |
DisclosureSEC source: 0001478242-25-000027 · wk-form4_1738973030.xml · derivative · entry 3 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,269 Underlying: Common Stock · 146 shares Expires not disclosed F4 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F4 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F4 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| February 05, 2025 Filed Feb 8, 2025 00:03 UTC |
Wims Morris LeslieDirector
|
GrantDeferred Shares · Derivative | 134 | $205.44 | $27,528.96 |
DisclosureSEC source: 0001478242-25-000026 · wk-form4_1738972979.xml · derivative · entry 1 Wims Morris Leslie · CIK 0001908079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,681 Underlying: Common Stock · 134 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| February 05, 2025 Filed Feb 8, 2025 00:02 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 170 | $205.44 | $34,924.80 |
DisclosureSEC source: 0001478242-25-000025 · wk-form4_1738972948.xml · derivative · entry 1 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,118 Underlying: Common Stock · 170 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| February 05, 2025 Filed Feb 8, 2025 00:01 UTC |
Fasano JimDirector
|
GrantDeferred Shares · Derivative | 171 | $205.44 | $35,130.24 |
DisclosureSEC source: 0001478242-25-000024 · wk-form4_1738972909.xml · derivative · entry 1 Fasano Jim · CIK 0001633043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,847 Underlying: Common Stock · 171 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| February 05, 2025 Filed Feb 8, 2025 00:01 UTC |
CONNAUGHTON JOHNDirector
|
GrantDeferred Shares · Derivative | 133 | $205.44 | $27,323.52 |
DisclosureSEC source: 0001478242-25-000023 · wk-form4_1738972883.xml · derivative · entry 1 CONNAUGHTON JOHN · CIK 0001213395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133 Underlying: Common Stock · 133 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 22:57 UTC |
Cherofsky KeriannSee Remarks
|
GrantStock Appreciation Right · Derivative | 2,633 | $0.00 Strike: $203.43 | $0.00 |
DisclosureSEC source: 0001478242-25-000012 · wk-form4_1738277869.xml · derivative · entry 4 Cherofsky Keriann · CIK 0001940591 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,633 Underlying: Common Stock · 2,633 shares Expires 2035-01-28 F3 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on January 28, 2026. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 22:57 UTC |
Cherofsky KeriannSee Remarks
|
Tax withholdingCommon Stock | 176 | $203.43 | $35,803.68 |
DisclosureSEC source: 0001478242-25-000012 · wk-form4_1738277869.xml · nonDerivative · entry 3 Cherofsky Keriann · CIK 0001940591 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,475 Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 22:57 UTC |
Cherofsky KeriannSee Remarks
|
GrantCommon Stock | 2,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-25-000012 · wk-form4_1738277869.xml · nonDerivative · entry 2 Cherofsky Keriann · CIK 0001940591 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,651 F2 · shares: Represents a grant of restricted stock units that will vest 100% on the third anniversary of the date of grant. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 22:57 UTC |
Cherofsky KeriannSee Remarks
|
GrantCommon Stock | 441 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-25-000012 · wk-form4_1738277869.xml · nonDerivative · entry 1 Cherofsky Keriann · CIK 0001940591 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,194 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 10 and July 28, 2022. The performance conditions applicable to the awards were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on January 28, 2025. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 22:56 UTC |
Patel BhavikSee Remarks
|
GrantStock Appreciation Right · Derivative | 10,534 | $0.00 Strike: $203.43 | $0.00 |
DisclosureSEC source: 0001478242-25-000010 · wk-form4_1738277790.xml · derivative · entry 3 Patel Bhavik · CIK 0002023629 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,534 Underlying: Common Stock · 10,534 shares Expires 2035-01-28 F2 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on January 28, 2026. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 22:56 UTC |
Patel BhavikSee Remarks
|
Tax withholdingCommon Stock | 612 | $203.43 | $124,499.16 |
DisclosureSEC source: 0001478242-25-000010 · wk-form4_1738277790.xml · nonDerivative · entry 2 Patel Bhavik · CIK 0002023629 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,232 Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 22:56 UTC |
Patel BhavikSee Remarks
|
GrantCommon Stock | 1,299 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-25-000010 · wk-form4_1738277790.xml · nonDerivative · entry 1 Patel Bhavik · CIK 0002023629 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,844 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 10 and July 28, 2022. The performance conditions applicable to the awards were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on January 28, 2025. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 22:57 UTC |
STAUB W RICHARDSee Remarks
|
GrantStock Appreciation Right · Derivative | 24,580 | $0.00 Strike: $203.43 | $0.00 |
DisclosureSEC source: 0001478242-25-000011 · wk-form4_1738277831.xml · derivative · entry 3 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,580 Underlying: Common Stock · 24,580 shares Expires 2035-01-28 F2 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on January 28, 2026. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 22:57 UTC |
STAUB W RICHARDSee Remarks
|
Tax withholdingCommon Stock | 479 | $203.43 | $97,442.97 |
DisclosureSEC source: 0001478242-25-000011 · wk-form4_1738277831.xml · nonDerivative · entry 2 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,037 Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 22:57 UTC |
STAUB W RICHARDSee Remarks
|
GrantCommon Stock | 1,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-25-000011 · wk-form4_1738277831.xml · nonDerivative · entry 1 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,516 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 10, 2022. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on January 28, 2025. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 22:55 UTC |
Sherbet EricSee Remarks
|
GrantStock Appreciation Right · Derivative | 14,045 | $0.00 Strike: $203.43 | $0.00 |
DisclosureSEC source: 0001478242-25-000009 · wk-form4_1738277750.xml · derivative · entry 3 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,045 Underlying: Common Stock · 14,045 shares Expires 2035-01-28 F2 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on January 28, 2026. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 22:55 UTC |
Sherbet EricSee Remarks
|
Tax withholdingCommon Stock | 605 | $203.43 | $123,075.15 |
DisclosureSEC source: 0001478242-25-000009 · wk-form4_1738277750.xml · nonDerivative · entry 2 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,287 Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 22:55 UTC |
Sherbet EricSee Remarks
|
GrantCommon Stock | 2,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-25-000009 · wk-form4_1738277750.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,892 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 10, 2022. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on January 28, 2025. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 22:55 UTC |
Bruehlman Ronald ESee Remarks
|
GrantStock Appreciation Right · Derivative | 31,603 | $0.00 Strike: $203.43 | $0.00 |
DisclosureSEC source: 0001478242-25-000008 · wk-form4_1738277713.xml · derivative · entry 4 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,603 Underlying: Common Stock · 31,603 shares Expires 2035-01-28 F3 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on January 28, 2026. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 22:55 UTC |
Bruehlman Ronald ESee Remarks
|
Tax withholdingCommon Stock | 2,201 | $203.43 | $447,749.43 |
DisclosureSEC source: 0001478242-25-000008 · wk-form4_1738277713.xml · nonDerivative · entry 2 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,476 Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 22:55 UTC |
Bruehlman Ronald ESee Remarks
|
GrantCommon Stock | 6,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-25-000008 · wk-form4_1738277713.xml · nonDerivative · entry 1 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,677 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 10, 2022. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on January 28, 2025. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 22:54 UTC |
BOUSBIB ARIDirector · See Remarks
|
GrantStock Appreciation Right · Derivative | 73,741 | $0.00 Strike: $203.43 | $0.00 |
DisclosureSEC source: 0001478242-25-000007 · wk-form4_1738277667.xml · derivative · entry 4 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,741 Underlying: Common Stock · 73,741 shares Expires 2035-01-28 F3 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on January 28, 2026. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 22:54 UTC |
BOUSBIB ARIDirector · See Remarks
|
Tax withholdingCommon Stock | 10,500 | $203.43 | $2,136,015.00 |
DisclosureSEC source: 0001478242-25-000007 · wk-form4_1738277667.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 797,083 Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 22:54 UTC |
BOUSBIB ARIDirector · See Remarks
|
GrantCommon Stock | 22,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-25-000007 · wk-form4_1738277667.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 807,583 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 10, 2022. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on January 28, 2025. Read SEC document |
| December 03, 2024 Filed Feb 8, 2025 00:03 UTC |
DANHAKL JOHN GDirector
|
PurchaseCommon Stock | 1,275 | $200.58 | $255,739.50 |
DisclosureSEC source: 0001478242-25-000027 · wk-form4_1738973030.xml · nonDerivative · entry 1 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 1,275 F1 · acquired: The purchase of shares was made without Mr. Danhakl's knowledge by an independent financial broker/advisor who manages the purchasing entity. F2 · ownership.nature: Shares held by an LLC controlled by the Danhakl Revocable Family Trust. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 22:00 UTC |
DANHAKL JOHN GDirector
|
GrantDeferred Shares · Derivative | 135 | $221.25 | $29,868.75 |
DisclosureSEC source: 0001478242-24-000122 · wk-form4_1731103238.xml · derivative · entry 1 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,123 Underlying: Common Stock · 135 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 22:02 UTC |
Wims Morris LeslieDirector
|
GrantDeferred Shares · Derivative | 124 | $221.25 | $27,435.00 |
DisclosureSEC source: 0001478242-24-000125 · wk-form4_1731103345.xml · derivative · entry 1 Wims Morris Leslie · CIK 0001908079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,547 Underlying: Common Stock · 124 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 22:01 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 158 | $221.25 | $34,957.50 |
DisclosureSEC source: 0001478242-24-000124 · wk-form4_1731103312.xml · derivative · entry 1 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,948 Underlying: Common Stock · 158 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 22:01 UTC |
Fasano JimDirector
|
GrantDeferred Shares · Derivative | 158 | $221.25 | $34,957.50 |
DisclosureSEC source: 0001478242-24-000123 · wk-form4_1731103281.xml · derivative · entry 1 Fasano Jim · CIK 0001633043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,676 Underlying: Common Stock · 158 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.